Skin Test Antigen [EPC]

Skin Test Antigen [EPC] was reported 2210 times

Drugs of the Skin Test Antigen [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 TUBERCULIN TEST FALSE POSITIVE 103 0.7803
1 ELECTROMYOGRAM NORMAL 1 0.5000
2 TUBERCULIN TEST NEGATIVE 3 0.3333
3 VACCINATION SITE NECROSIS 1 0.3333
4 FALSE POSITIVE TUBERCULOSIS TEST 96 0.3232
5 VACCINATION SITE INDURATION 6 0.2400
6 BLOOD CADMIUM INCREASED 1 0.2000
7 VACCINATION SITE IRRITATION 1 0.2000
8 VACCINATION SITE INFLAMMATION 8 0.1818
9 VACCINATION SITE PRURITUS 7 0.1667
10 VACCINATION SITE RASH 5 0.1613
11 NO ADVERSE DRUG REACTION 10 0.1429
12 EXTENSIVE SWELLING OF VACCINATED LIMB 3 0.1429
13 VACCINATION SITE CELLULITIS 2 0.1429
14 VACCINATION SITE VESICLES 2 0.1250
15 TUBERCULOSIS SKIN TEST POSITIVE 9 0.1111
16 GASTROENTERITIS NORWALK VIRUS 2 0.1053
17 COW POX 1 0.1000
18 VACCINATION SITE LYMPHADENOPATHY 1 0.1000
19 VACCINATION SITE ERYTHEMA 10 0.0654
20 MANUFACTURING PRODUCT STORAGE ISSUE 4 0.0556
21 BLADDER NECK OPERATION 1 0.0500
22 VACCINATION SITE BRUISING 1 0.0435
23 POOR QUALITY PRODUCT ADMINISTERED 239 0.0435
24 OVARIAN INFECTION 1 0.0417
25 VACCINATION SITE REACTION 3 0.0370
26 POLYMORPHIC ERUPTION OF PREGNANCY 1 0.0357
27 OILY SKIN 1 0.0256
28 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST 1 0.0256
29 INTRANASAL PARAESTHESIA 1 0.0250
30 EXPOSURE VIA EYE CONTACT 6 0.0221
31 DIALYSIS HYPOTENSION 1 0.0217
32 HISTAMINE ABNORMAL 1 0.0213
33 URTICARIA LOCALISED 1 0.0213
34 FACTOR VII DEFICIENCY 1 0.0192
35 ERYTHEMA INDURATUM 2 0.0180
36 RENAL SCAN ABNORMAL 1 0.0172
37 LYMPHOCYTE COUNT 1 0.0169
38 WRONG PRODUCT ADMINISTERED 70 0.0159
39 PENILE ABSCESS 1 0.0159
40 PEPTOSTREPTOCOCCUS INFECTION 1 0.0128
41 KOEBNER PHENOMENON 1 0.0128
42 INDURATION 18 0.0120
43 VISUAL FIELD TESTS ABNORMAL 1 0.0115
44 LOCAL REACTION 7 0.0114
45 PARAESTHESIA MUCOSAL 1 0.0114
46 TRACHEAL INFLAMMATION 1 0.0109
47 AGONAL RESPIRATION 1 0.0109
48 TUBERCULIN TEST POSITIVE 26 0.0108
49 PITUITARY CYST 1 0.0105
50 INJECTION SITE STREAKING 2 0.0103
51 INJECTION SITE INDURATION 114 0.0102
52 SYNCOPE VASOVAGAL 8 0.0096
53 BASAL GANGLIA STROKE 1 0.0096
54 RASH SCALY 1 0.0095
55 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0094
56 INJECTION SITE OEDEMA 13 0.0094
57 INJECTED LIMB MOBILITY DECREASED 1 0.0093
58 UNRESPONSIVE TO VERBAL STIMULI 2 0.0093
59 REGURGITATION OF FOOD 1 0.0093
60 VACCINATION SITE PAIN 4 0.0092
61 INJECTION SITE VESICLES 39 0.0091
62 ALLERGY TO VACCINE 2 0.0086
63 INJECTION SITE DERMATITIS 1 0.0085
64 ARTERIOVENOUS FISTULA SITE INFECTION 1 0.0081
65 INCISION SITE OEDEMA 1 0.0079
66 PARAKERATOSIS 2 0.0077
67 ACANTHOSIS 2 0.0075
68 INJECTION SITE CELLULITIS 11 0.0073
69 BRACHIAL PLEXUS INJURY 1 0.0070
70 WRONG DRUG ADMINISTERED 61 0.0068
71 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0064
72 PRURITUS ALLERGIC 6 0.0063
73 URTICARIA GENERALISED 4 0.0062
74 PRODUCT STORAGE ERROR 291 0.0061
75 APPLICATION SITE HAEMATOMA 1 0.0058
76 BRACHIAL PLEXOPATHY 1 0.0057
77 EYE ROLLING 4 0.0057
78 SHOULDER DEFORMITY 1 0.0056
79 HEPATITIS A ANTIBODY POSITIVE 1 0.0055
80 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0053
81 TESTICULAR MASS 1 0.0053
82 FAECAL OCCULT BLOOD POSITIVE 1 0.0052
83 INJECTION SITE NERVE DAMAGE 1 0.0052
84 SKIN INFLAMMATION 1 0.0051
85 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 56 0.0051
86 VOCAL CORD PARESIS 1 0.0051
87 CORNEAL THINNING 1 0.0049
88 INJECTION SITE INFLAMMATION 18 0.0047
89 EXPIRED PRODUCT ADMINISTERED 123 0.0046
90 LACUNAR STROKE 1 0.0045
91 ERYTHEMA INFECTIOSUM 1 0.0044
92 BLOOD CREATINE DECREASED 1 0.0043
93 ANION GAP DECREASED 1 0.0042
94 INJECTION SITE CYST 1 0.0042
95 LATEX ALLERGY 1 0.0041
96 GLOBULINS DECREASED 1 0.0040
97 LYMPH NODE PAIN 6 0.0039
98 ADMINISTRATION SITE SWELLING 1 0.0039
99 CORNEAL INFILTRATES 1 0.0039
100 TONIC CLONIC MOVEMENTS 4 0.0039
101 SCARLET FEVER 1 0.0039
102 CAT SCRATCH DISEASE 1 0.0039
103 LOSS OF PROPRIOCEPTION 1 0.0038
104 SKIN TEST POSITIVE 3 0.0037
105 SUSPECTED PRODUCT QUALITY ISSUE 4 0.0037
106 SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0036
107 BASAL GANGLIA INFARCTION 1 0.0035
108 INJECTION SITE PUSTULE 1 0.0035
109 RENAL HYPERTENSION 1 0.0035
110 PROTEUS INFECTION 2 0.0035
111 SKIN BACTERIAL INFECTION 2 0.0035
112 SUBCUTANEOUS NODULE 1 0.0035
113 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 1 0.0034
114 SCROTAL ABSCESS 1 0.0034
115 BURNING SENSATION MUCOSAL 1 0.0034
116 INJECTION SITE WARMTH 60 0.0033
117 LYMPHOID TISSUE HYPERPLASIA 1 0.0033
118 GAIT SPASTIC 1 0.0032
119 BRAIN CONTUSION 2 0.0031
120 BODY MASS INDEX INCREASED 3 0.0030
121 SKIN WARM 14 0.0030
122 TONIC CONVULSION 3 0.0029
123 INJECTION SITE NECROSIS 5 0.0028
124 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0027
125 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0027
126 LACK OF SPONTANEOUS SPEECH 1 0.0026
127 LYMPHADENITIS 5 0.0026
128 POOR QUALITY DRUG ADMINISTERED 17 0.0026
129 INJECTION SITE IRRITATION 27 0.0026
130 INJECTION SITE BURNING 2 0.0026
131 ARTERIOVENOUS MALFORMATION 2 0.0025
132 AXILLARY PAIN 3 0.0025
133 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0025
134 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0024
135 INJECTION SITE RASH 55 0.0024
136 ACCIDENTAL EXPOSURE 10 0.0024
137 INJECTION SITE ERYTHEMA 239 0.0024
138 TRACHEAL DISORDER 1 0.0024
139 SKIN OEDEMA 2 0.0024
140 KELOID SCAR 1 0.0023
141 CORNEAL EPITHELIUM DEFECT 1 0.0022
142 INJECTION SITE PRURITUS 119 0.0022
143 DRUG ADMINISTRATION ERROR 67 0.0022
144 PRE-EXISTING DISEASE 1 0.0021
145 POSTURING 1 0.0021
146 CHEST X-RAY ABNORMAL 6 0.0021
147 INCORRECT ROUTE OF DRUG ADMINISTRATION 76 0.0021
148 STATUS ASTHMATICUS 1 0.0021
149 FOOD REFUSAL 1 0.0021
150 SENSATION OF HEAVINESS 8 0.0021
151 MARKEDLY REDUCED DIETARY INTAKE 1 0.0020
152 PULSE PRESSURE DECREASED 1 0.0020
153 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0020
154 HYPOAESTHESIA FACIAL 3 0.0020
155 PERNICIOUS ANAEMIA 1 0.0019
156 ENTEROCOCCUS TEST POSITIVE 1 0.0019
157 DELIVERY 1 0.0019
158 GUILLAIN-BARRE SYNDROME 7 0.0019
159 CERVICOBRACHIAL SYNDROME 1 0.0018
160 INJECTION SITE DISCOLOURATION 18 0.0018
161 SUSPECTED PRODUCT CONTAMINATION 1 0.0018
162 ANTERIOR CHAMBER CELL 1 0.0018
163 SOFT TISSUE NECROSIS 1 0.0018
164 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0018
165 REFLEXES ABNORMAL 1 0.0017
166 CROUP INFECTIOUS 1 0.0017
167 TONGUE PRURITUS 1 0.0017
168 ALLODYNIA 1 0.0017
169 ORAL PRURITUS 3 0.0017
170 OCCUPATIONAL EXPOSURE TO PRODUCT 8 0.0016
171 TONGUE PARALYSIS 1 0.0016
172 VITAL FUNCTIONS ABNORMAL 1 0.0016
173 PNEUMONIA CRYPTOCOCCAL 1 0.0016
174 LYMPH NODE TUBERCULOSIS 1 0.0016
175 ESCHAR 1 0.0015
176 LOCALISED OEDEMA 6 0.0015
177 REACTION TO PRESERVATIVES 1 0.0015
178 INJECTION SITE URTICARIA 27 0.0015
179 INJECTION SITE ABSCESS 3 0.0015
180 ANAPHYLACTOID REACTION 5 0.0015
181 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0014
182 LABORATORY TEST INTERFERENCE 1 0.0014
183 STARING 3 0.0014
184 AORTIC DISORDER 1 0.0014
185 EXCESSIVE GRANULATION TISSUE 1 0.0014
186 THROAT TIGHTNESS 31 0.0014
187 BLADDER CATHETERISATION 1 0.0014
188 NEPHROGENIC ANAEMIA 6 0.0014
189 LUNG HYPERINFLATION 1 0.0014
190 FOOD INTERACTION 2 0.0013
191 DEAFNESS TRANSITORY 1 0.0013
192 PERTUSSIS 1 0.0013
193 ADMINISTRATION SITE PAIN 1 0.0013
194 INJECTION SITE SCAB 1 0.0013
195 SPUTUM CULTURE POSITIVE 1 0.0013
196 SERUM SICKNESS 3 0.0013
197 COLOUR BLINDNESS 1 0.0013
198 CULTURE POSITIVE 1 0.0013
199 STRIDOR 3 0.0012
200 BREAST ABSCESS 1 0.0012
201 PARAESTHESIA ORAL 14 0.0012
202 EAR HAEMORRHAGE 2 0.0012
203 PRURIGO 1 0.0012
204 LYMPHOCYTIC INFILTRATION 1 0.0012
205 CARPAL TUNNEL DECOMPRESSION 1 0.0012
206 LIVEDO RETICULARIS 2 0.0012
207 FALSE POSITIVE INVESTIGATION RESULT 1 0.0012
208 PRODUCT CONTAMINATION MICROBIAL 1 0.0011
209 NEUROMYOPATHY 1 0.0011
210 LYME DISEASE 3 0.0011
211 CHRONIC RESPIRATORY FAILURE 1 0.0011
212 GROIN ABSCESS 1 0.0011
213 NAIL GROWTH ABNORMAL 1 0.0011
214 EXPOSURE VIA SKIN CONTACT 3 0.0011
215 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0011
216 INJECTION SITE SWELLING 62 0.0011
217 PHARYNGEAL OEDEMA 16 0.0011
218 IMMEDIATE POST-INJECTION REACTION 1 0.0010
219 SHOULDER PAIN 1 0.0010
220 INJECTION SITE REACTION 57 0.0010
221 ESCHERICHIA TEST POSITIVE 1 0.0010
222 PALLOR 23 0.0010
223 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0010
224 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
225 ALVEOLITIS ALLERGIC 1 0.0010
226 MULTIMORBIDITY 1 0.0010
227 INJECTION SITE PARAESTHESIA 1 0.0010
228 CARBON DIOXIDE INCREASED 1 0.0009
229 BLOOD UREA DECREASED 1 0.0009
230 NO ADVERSE EVENT 112 0.0009
231 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
232 PRESYNCOPE 18 0.0009
233 REACTION TO DRUG EXCIPIENTS 2 0.0009
234 VACCINATION FAILURE 1 0.0009
235 INJECTION SITE SCAR 2 0.0009
236 PRODUCT QUALITY ISSUE 109 0.0009
237 OPEN WOUND 1 0.0009
238 APPLICATION SITE WARMTH 1 0.0009
239 AREFLEXIA 2 0.0009
240 LARYNGOSPASM 2 0.0009
241 RASH ERYTHEMATOUS 29 0.0009
242 HYPERPARATHYROIDISM SECONDARY 2 0.0009
243 TENOSYNOVITIS 2 0.0008
244 EAR PRURITUS 2 0.0008
245 SEIZURE LIKE PHENOMENA 1 0.0008
246 EOSINOPHIL COUNT DECREASED 1 0.0008
247 TENDERNESS 7 0.0008
248 INJECTION SITE PAPULE 3 0.0008
249 MENINGITIS CRYPTOCOCCAL 1 0.0008
250 PRURITUS GENERALISED 17 0.0008
251 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9 0.0008
252 PAPILLOMA VIRAL INFECTION 1 0.0008
253 PULMONARY FUNCTION TEST ABNORMAL 1 0.0008
254 COMPLEX REGIONAL PAIN SYNDROME 1 0.0008
255 ANGIONEUROTIC OEDEMA 2 0.0007
256 ANAPHYLACTIC REACTION 31 0.0007
257 HYPOPNOEA 2 0.0007
258 SKULL FRACTURE 1 0.0007
259 PUSTULAR PSORIASIS 2 0.0007
260 NONSPECIFIC REACTION 3 0.0007
261 GRANULOMA 2 0.0007
262 VENA CAVA THROMBOSIS 1 0.0007
263 ERYTHEMA 118 0.0007
264 CHOREA 1 0.0007
265 POLYCYTHAEMIA 1 0.0007
266 INTERMITTENT CLAUDICATION 1 0.0007
267 PHARMACEUTICAL PRODUCT COMPLAINT 18 0.0007
268 SPINAL DEFORMITY 1 0.0007
269 SACROILIITIS 1 0.0007
270 INJECTION SITE DISCHARGE 1 0.0007
271 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
272 PHLEBITIS 3 0.0007
273 VOCAL CORD PARALYSIS 1 0.0007
274 DERMATITIS PSORIASIFORM 1 0.0007
275 DYSENTERY 1 0.0007
276 SKIN LESION 14 0.0007
277 SWOLLEN TONGUE 17 0.0006
278 NASAL SEPTUM DEVIATION 1 0.0006
279 PRODUCT CONTAMINATION PHYSICAL 1 0.0006
280 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
281 LATENT TUBERCULOSIS 1 0.0006
282 OESOPHAGEAL SPASM 1 0.0006
283 RASH GENERALISED 16 0.0006
284 WHEEZING 27 0.0006
285 CONVERSION DISORDER 1 0.0006
286 ESCHERICHIA BACTERAEMIA 1 0.0006
287 RASH PUSTULAR 4 0.0006
288 BILIARY DYSKINESIA 1 0.0006
289 SELF-MEDICATION 2 0.0006
290 RESPIRATION ABNORMAL 3 0.0006
291 RASH PAPULAR 11 0.0006
292 BLISTER 25 0.0006
293 MICROCYTIC ANAEMIA 1 0.0006
294 TUBERCULOSIS 6 0.0006
295 PHARYNGOLARYNGEAL PAIN 3 0.0006
296 MUSCLE CRAMP 1 0.0006
297 CORNEAL DISORDER 1 0.0006
298 DROOLING 3 0.0006
299 NEUROGENIC BLADDER 1 0.0006
300 ATRIAL THROMBOSIS 1 0.0006
301 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0006
302 HYPERSENSITIVITY 83 0.0006
303 FLAT AFFECT 1 0.0005
304 PURULENT DISCHARGE 2 0.0005
305 MONOPLEGIA 2 0.0005
306 PERIARTHRITIS 1 0.0005
307 GRAND MAL CONVULSION 5 0.0005
308 URTICARIA 70 0.0005
309 INFECTIOUS MONONUCLEOSIS 1 0.0005
310 EYELID DISORDER 1 0.0005
311 DERMATOMYOSITIS 1 0.0005
312 LYMPHADENOPATHY 15 0.0005
313 EMERGENCY CARE 1 0.0005
314 PRE-ECLAMPSIA 2 0.0005
315 PARESIS 1 0.0005
316 PULSE ABNORMAL 1 0.0005
317 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0005
318 VARICELLA 1 0.0005
319 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
320 ACUTE PSYCHOSIS 1 0.0005
321 NEAR DEATH EXPERIENCE 1 0.0005
322 DILATATION VENTRICULAR 1 0.0005
323 PROCTITIS 1 0.0005
324 UNRESPONSIVE TO STIMULI 10 0.0005
325 APPLICATION SITE URTICARIA 1 0.0005
326 RASH PRURITIC 20 0.0005
327 INCORRECT DOSE ADMINISTERED 72 0.0005
328 IMPAIRED SELF-CARE 1 0.0005
329 HAEMORRHAGE URINARY TRACT 1 0.0005
330 VASODILATATION 1 0.0005
331 ESSENTIAL HYPERTENSION 1 0.0005
332 ABDOMINAL RIGIDITY 1 0.0005
333 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0005
334 FACIAL PALSY 1 0.0005
335 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0005
336 LOCAL SWELLING 8 0.0005
337 SENSATION OF FOREIGN BODY 3 0.0005
338 CYANOSIS 6 0.0005
339 SKIN FRAGILITY 1 0.0004
340 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
341 DEAFNESS UNILATERAL 2 0.0004
342 URINE OUTPUT INCREASED 1 0.0004
343 PRODUCT CONTAMINATION 1 0.0004
344 SKIN REACTION 5 0.0004
345 RASH MACULAR 12 0.0004
346 CLONUS 1 0.0004
347 NECK MASS 1 0.0004
348 NYSTAGMUS 2 0.0004
349 EOSINOPHILIC PNEUMONIA 1 0.0004
350 CELLULITIS 18 0.0004
351 PRURITUS 116 0.0004
352 MASS 5 0.0004
353 SENSORY DISTURBANCE 6 0.0004
354 SYNCOPE 35 0.0004
355 HYPERAESTHESIA 3 0.0004
356 RESPIRATORY RATE INCREASED 3 0.0004
357 JOINT LOCK 1 0.0004
358 EMBOLISM VENOUS 1 0.0004
359 ESCHERICHIA SEPSIS 1 0.0004
360 TYPE I HYPERSENSITIVITY 1 0.0004
361 MYELOFIBROSIS 1 0.0004
362 MUSCLE RIGIDITY 4 0.0004
363 DYSAESTHESIA 1 0.0004
364 PYODERMA GANGRENOSUM 1 0.0004
365 COLD SWEAT 6 0.0004
366 INJECTION SITE PAIN 91 0.0004
367 CUSHINGOID 1 0.0004
368 EXPIRED DRUG ADMINISTERED 2 0.0004
369 LIP SWELLING 11 0.0004
370 PURPURA 3 0.0004
371 NECK INJURY 1 0.0004
372 HYPOAESTHESIA ORAL 5 0.0004
373 THROAT IRRITATION 14 0.0004
374 EXCORIATION 1 0.0004
375 DIASTOLIC DYSFUNCTION 1 0.0004
376 FEELING HOT 20 0.0004
377 ERYTHEMA MULTIFORME 3 0.0004
378 ABSCESS 5 0.0004
379 INFLAMMATION 15 0.0004
380 EXTRA DOSE ADMINISTERED 9 0.0004
381 ONYCHOMADESIS 1 0.0004
382 PRODUCT ADMINISTRATION ERROR 5 0.0004
383 PREMATURE LABOUR 2 0.0004
384 ENCEPHALITIS 2 0.0004
385 BLOOD BLISTER 1 0.0004
386 CREPITATIONS 1 0.0004
387 POSTURE ABNORMAL 1 0.0004
388 VENTRICULAR HYPOKINESIA 1 0.0004
389 ATELECTASIS 3 0.0004
390 PROTHROMBIN TIME PROLONGED 2 0.0004
391 LOOSE TOOTH 1 0.0004
392 END STAGE RENAL DISEASE 6 0.0004
393 ACCIDENTAL OVERDOSE 10 0.0004
394 CHEST DISCOMFORT 29 0.0004
395 THROMBOCYTOSIS 1 0.0004
396 CHRONIC SINUSITIS 1 0.0004
397 STUPOR 1 0.0004
398 GENERALISED ERYTHEMA 2 0.0004
399 PETECHIAE 3 0.0003
400 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
401 FEELING COLD 8 0.0003
402 RASH MACULO-PAPULAR 6 0.0003
403 ECCHYMOSIS 2 0.0003
404 SWELLING FACE 18 0.0003
405 PHARYNGEAL SWELLING 2 0.0003
406 LIVER TRANSPLANT 1 0.0003
407 REBOUND ACID HYPERSECRETION 1 0.0003
408 BLINDNESS TRANSIENT 2 0.0003
409 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
410 RESPIRATORY ACIDOSIS 1 0.0003
411 MEDICATION ERROR 15 0.0003
412 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
413 PAROSMIA 2 0.0003
414 HYPERACUSIS 1 0.0003
415 BREAST PAIN 3 0.0003
416 PROTEIN TOTAL DECREASED 1 0.0003
417 INVESTIGATION 1 0.0003
418 ANAL INCONTINENCE 2 0.0003
419 THROMBOSIS IN DEVICE 1 0.0003
420 FACIAL PARESIS 1 0.0003
421 OEDEMA MOUTH 1 0.0003
422 HYPOAESTHESIA 39 0.0003
423 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0003
424 TONGUE DISORDER 2 0.0003
425 MUSCLE HAEMORRHAGE 1 0.0003
426 SWELLING 23 0.0003
427 STAPHYLOCOCCAL BACTERAEMIA 1 0.0003
428 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
429 BLOOD ALBUMIN DECREASED 2 0.0003
430 CYTOLYTIC HEPATITIS 1 0.0003
431 ABSCESS LIMB 1 0.0003
432 TRIGEMINAL NEURALGIA 1 0.0003
433 SENSORY LOSS 2 0.0003
434 SKIN PLAQUE 2 0.0003
435 WOUND SECRETION 1 0.0003
436 LETHARGY 14 0.0003
437 VIITH NERVE PARALYSIS 1 0.0003
438 INJECTION SITE HAEMATOMA 4 0.0003
439 SCRATCH 2 0.0003
440 PARAESTHESIA 38 0.0003
441 EYELID OEDEMA 3 0.0003
442 LIP OEDEMA 1 0.0003
443 FACE OEDEMA 4 0.0003
444 CONVULSION 16 0.0003
445 RASH VESICULAR 1 0.0003
446 LIMB DISCOMFORT 7 0.0003
447 SCAR 4 0.0003
448 BLOOD CREATINE INCREASED 1 0.0003
449 LEFT VENTRICULAR HYPERTROPHY 1 0.0003
450 APPLICATION SITE EXFOLIATION 1 0.0003
451 INJECTION SITE DISCOMFORT 2 0.0003
452 TEARFULNESS 1 0.0003
453 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
454 INCORRECT DOSAGE ADMINISTERED 1 0.0003
455 PERIPHERAL COLDNESS 3 0.0003
456 SARCOIDOSIS 1 0.0003
457 GESTATIONAL DIABETES 1 0.0003
458 BURNING SENSATION 15 0.0003
459 SKIN TIGHTNESS 1 0.0003
460 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
461 SUBCUTANEOUS ABSCESS 1 0.0002
462 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
463 PROTEIN URINE PRESENT 1 0.0002
464 HYPERNATRAEMIA 1 0.0002
465 CATATONIA 1 0.0002
466 FLUSHING 22 0.0002
467 EAR DISCOMFORT 2 0.0002
468 PETIT MAL EPILEPSY 1 0.0002
469 TONSILLITIS 1 0.0002
470 PAIN IN EXTREMITY 60 0.0002
471 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
472 ABDOMINAL TENDERNESS 1 0.0002
473 BURSITIS 2 0.0002
474 BLOOD PRESSURE DECREASED 13 0.0002
475 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0002
476 CHILLS 23 0.0002
477 STREPTOCOCCAL INFECTION 1 0.0002
478 SKIN DISCOLOURATION 9 0.0002
479 COLECTOMY 1 0.0002
480 EYE SWELLING 7 0.0002
481 PERIORBITAL OEDEMA 1 0.0002
482 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
483 HYPOTONIA 2 0.0002
484 DYSGEUSIA 15 0.0002
485 SKIN INFECTION 2 0.0002
486 BODY TEMPERATURE INCREASED 4 0.0002
487 SKIN IRRITATION 9 0.0002
488 INCORRECT PRODUCT STORAGE 3 0.0002
489 INCONTINENCE 2 0.0002
490 DYSPHAGIA 17 0.0002
491 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
492 OEDEMA PERIPHERAL 24 0.0002
493 SKIN NECROSIS 1 0.0002
494 PYREXIA 63 0.0002
495 APPLICATION SITE SWELLING 1 0.0002
496 HYPERKERATOSIS 1 0.0002
497 RASH 73 0.0002
498 LOSS OF CONSCIOUSNESS 23 0.0002
499 FEAR OF INJECTION 1 0.0002
500 INCREASED UPPER AIRWAY SECRETION 1 0.0002
501 DYSPHONIA 10 0.0002
502 HYPERTENSIVE CRISIS 2 0.0002
503 NERVE INJURY 2 0.0002
504 HYPERHIDROSIS 23 0.0002
505 JOINT RANGE OF MOTION DECREASED 2 0.0002
506 BLOOD CALCIUM DECREASED 2 0.0002
507 FOOD ALLERGY 1 0.0002
508 PHOTOPHOBIA 3 0.0002
509 PERONEAL NERVE PALSY 1 0.0002
510 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
511 ANGIOPATHY 1 0.0002
512 ILEUS 2 0.0002
513 LEUKOCYTOSIS 3 0.0002
514 RESPIRATORY DISORDER 5 0.0002
515 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
516 FEAR 5 0.0002
517 OVERDOSE 36 0.0002
518 APPETITE DISORDER 1 0.0002
519 URINARY INCONTINENCE 5 0.0002
520 HEART RATE DECREASED 6 0.0002
521 MYOCLONUS 2 0.0002
522 ANAPHYLACTIC SHOCK 4 0.0002
523 CARDIAC VALVE DISEASE 1 0.0002
524 PAPULE 1 0.0002
525 HYPERVENTILATION 1 0.0002
526 HEART RATE INCREASED 16 0.0002
527 DYSPNOEA 91 0.0002
528 PRODUCT LABEL ISSUE 1 0.0002
529 DRUG DISPENSING ERROR 3 0.0002
530 SCOLIOSIS 1 0.0002
531 PHOTOPSIA 1 0.0002
532 NODULE 2 0.0002
533 PULMONARY CONGESTION 2 0.0002
534 PLATELET COUNT INCREASED 2 0.0002
535 HEPATITIS ACUTE 1 0.0002
536 PALPITATIONS 18 0.0002
537 MENINGITIS 1 0.0002
538 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0002
539 LEFT VENTRICULAR DYSFUNCTION 1 0.0002
540 LYMPHOEDEMA 1 0.0002
541 APHONIA 2 0.0002
542 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
543 MUSCLE SPASTICITY 2 0.0002
544 ONYCHOCLASIS 1 0.0002
545 NEPHROTIC SYNDROME 1 0.0002
546 INJECTION SITE BRUISING 11 0.0002
547 ULCER HAEMORRHAGE 1 0.0002
548 SKIN SWELLING 1 0.0002
549 BRADYCARDIA 8 0.0002
550 DYSKINESIA 6 0.0002
551 STAPHYLOCOCCAL INFECTION 5 0.0002
552 EYE MOVEMENT DISORDER 1 0.0002
553 ABORTION SPONTANEOUS 6 0.0002
554 OCULAR HYPERAEMIA 6 0.0002
555 RESPIRATORY DISTRESS 4 0.0002
556 GRIP STRENGTH DECREASED 1 0.0002
557 MUSCULAR WEAKNESS 16 0.0002
558 HAEMATOCRIT DECREASED 3 0.0002
559 MAJOR DEPRESSION 1 0.0002
560 DUODENAL ULCER 1 0.0002
561 GASTROENTERITIS 2 0.0002
562 OROPHARYNGEAL DISCOMFORT 1 0.0002
563 DIZZINESS 68 0.0002
564 BRONCHOSPASM 2 0.0002
565 THERMAL BURN 1 0.0002
566 ORAL DISORDER 1 0.0002
567 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0002
568 HYDRONEPHROSIS 1 0.0002
569 FORMICATION 1 0.0002
570 HYPOKINESIA 2 0.0002
571 IMMUNOSUPPRESSION 1 0.0002
572 IMPAIRED WORK ABILITY 3 0.0002
573 COORDINATION ABNORMAL 2 0.0002
574 RESPIRATORY TRACT CONGESTION 2 0.0002
575 ESCHERICHIA INFECTION 1 0.0002
576 MELAENA 3 0.0002
577 MUSCULOSKELETAL CHEST PAIN 2 0.0002
578 HEAD INJURY 4 0.0002
579 TREMOR 22 0.0002
580 ATRIOVENTRICULAR BLOCK 1 0.0002
581 PSEUDOMONAS INFECTION 1 0.0002
582 MUSCLE TWITCHING 3 0.0002
583 FACIAL PARALYSIS 1 0.0002
584 PNEUMONIA BACTERIAL 1 0.0002
585 MUSCULOSKELETAL STIFFNESS 11 0.0002
586 ULCER 2 0.0002
587 SYNOVITIS 2 0.0002
588 PRODUCT PACKAGING QUANTITY ISSUE 1 0.0002
589 TUMOUR LYSIS SYNDROME 1 0.0002
590 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
591 AORTIC ANEURYSM 1 0.0002
592 CONJUNCTIVITIS 2 0.0002
593 DEVICE RELATED INFECTION 2 0.0002
594 MYOSITIS 1 0.0001
595 BLOOD POTASSIUM INCREASED 2 0.0001
596 BLOOD MAGNESIUM DECREASED 1 0.0001
597 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
598 APNOEA 1 0.0001
599 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
600 RENAL CYST 1 0.0001
601 PULMONARY HAEMORRHAGE 1 0.0001
602 CHEST PAIN 23 0.0001
603 DRUG HYPERSENSITIVITY 24 0.0001
604 ATRIAL FLUTTER 1 0.0001
605 BLOOD PRESSURE FLUCTUATION 3 0.0001
606 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
607 GASTROINTESTINAL INFECTION 1 0.0001
608 EMBOLISM 1 0.0001
609 DIZZINESS POSTURAL 1 0.0001
610 ANGIOEDEMA 5 0.0001
611 SKIN HYPERPIGMENTATION 1 0.0001
612 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
613 LYMPHOCYTE COUNT DECREASED 2 0.0001
614 BRAIN NEOPLASM 1 0.0001
615 MIDDLE INSOMNIA 2 0.0001
616 WOUND INFECTION 1 0.0001
617 FLUID OVERLOAD 2 0.0001
618 PATHOGEN RESISTANCE 1 0.0001
619 HEMIPARESIS 2 0.0001
620 BLOOD PRESSURE INCREASED 17 0.0001
621 OROPHARYNGEAL PAIN 10 0.0001
622 PERIPHERAL SWELLING 16 0.0001
623 SPINAL OSTEOARTHRITIS 1 0.0001
624 ATRIAL SEPTAL DEFECT 1 0.0001
625 EYE PRURITUS 3 0.0001
626 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
627 RESTLESS LEGS SYNDROME 2 0.0001
628 INJECTION SITE HAEMORRHAGE 8 0.0001
629 NEUTROPHIL COUNT DECREASED 4 0.0001
630 FLANK PAIN 1 0.0001
631 OPTIC NEURITIS 1 0.0001
632 LUNG INFECTION 2 0.0001
633 EAR PAIN 2 0.0001
634 VITAMIN D DEFICIENCY 1 0.0001
635 TEMPERATURE INTOLERANCE 1 0.0001
636 WEIGHT FLUCTUATION 1 0.0001
637 RENAL TUBULAR NECROSIS 1 0.0001
638 LUNG INFILTRATION 1 0.0001
639 COUGH 27 0.0001
640 NEPHROPATHY 1 0.0001
641 SLEEP APNOEA SYNDROME 2 0.0001
642 PSYCHOTIC DISORDER 3 0.0001
643 MUSCULOSKELETAL DISORDER 2 0.0001
644 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
645 PHARYNGITIS STREPTOCOCCAL 1 0.0001
646 LARYNGITIS 1 0.0001
647 ASPIRATION 1 0.0001
648 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
649 SUBARACHNOID HAEMORRHAGE 1 0.0001
650 NEUTROPHIL COUNT INCREASED 1 0.0001
651 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
652 BODY TEMPERATURE DECREASED 1 0.0001
653 SNEEZING 2 0.0001
654 HEPATOMEGALY 1 0.0001
655 MALNUTRITION 1 0.0001
656 SKIN DISORDER 3 0.0001
657 ASTHENIA 35 0.0001
658 NAUSEA 73 0.0001
659 DERMATITIS CONTACT 1 0.0001
660 NASAL CONGESTION 5 0.0001
661 SCAB 1 0.0001
662 SECRETION DISCHARGE 1 0.0001
663 POLYNEUROPATHY 1 0.0001
664 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
665 STATUS EPILEPTICUS 1 0.0001
666 AMNESIA 6 0.0001
667 DERMATITIS ALLERGIC 1 0.0001
668 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
669 INJECTION SITE NODULE 1 0.0001
670 TINNITUS 4 0.0001
671 LACERATION 1 0.0001
672 SCHIZOPHRENIA 1 0.0001
673 STEVENS-JOHNSON SYNDROME 2 0.0001
674 IMPAIRED DRIVING ABILITY 1 0.0001
675 EXPOSURE DURING PREGNANCY 5 0.0001
676 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
677 CONTUSION 8 0.0001
678 GENERALISED OEDEMA 1 0.0001
679 EYE IRRITATION 4 0.0001
680 HEADACHE 52 0.0001
681 PNEUMONIA ASPIRATION 2 0.0001
682 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
683 SEASONAL ALLERGY 1 0.0001
684 EYE PAIN 4 0.0001
685 PAIN 50 0.0001
686 RESPIRATORY DEPRESSION 1 0.0001
687 BALANCE DISORDER 7 0.0001
688 GINGIVAL BLEEDING 1 0.0001
689 DYSARTHRIA 3 0.0001
690 TOOTH EXTRACTION 1 0.0001
691 JOINT SWELLING 9 0.0001
692 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
693 TACHYPNOEA 1 0.0001
694 SEIZURE 8 0.0001
695 HAEMATOCHEZIA 4 0.0001
696 HAEMATEMESIS 2 0.0001
697 BEDRIDDEN 1 0.0001
698 SPEECH DISORDER 4 0.0001
699 VOMITING 34 0.0001
700 LACRIMATION INCREASED 2 0.0001
701 ARTHRALGIA 29 0.0001
702 HEPATITIS C 1 0.0001
703 HAIR COLOUR CHANGES 1 0.0001
704 FEELING ABNORMAL 18 0.0001
705 ORAL DISCOMFORT 1 0.0001
706 DEEP VEIN THROMBOSIS 5 0.0001
707 PULMONARY MASS 1 0.0001
708 MENTAL STATUS CHANGES 2 0.0001
709 RED BLOOD CELL COUNT DECREASED 2 0.0001
710 MYALGIA 12 0.0001
711 HYPOTENSION 14 0.0001
712 RENAL FAILURE 10 0.0001
713 INFLUENZA LIKE ILLNESS 6 0.0001
714 PRODUCT PREPARATION ERROR 1 0.0001
715 MUSCULOSKELETAL PAIN 4 0.0001
716 PARALYSIS 1 0.0001
717 ECZEMA 2 0.0001
718 DIALYSIS 1 0.0001
719 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
720 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
721 VISION BLURRED 9 0.0001
722 GAIT DISTURBANCE 13 0.0001
723 ABASIA 2 0.0001
724 THYROID DISORDER 1 0.0001
725 PULMONARY OEDEMA 3 0.0001
726 CANDIDA INFECTION 1 0.0001
727 RHINORRHOEA 4 0.0001
728 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
729 APHASIA 2 0.0001
730 VIRAL INFECTION 2 0.0001
731 LUNG DISORDER 3 0.0001
732 ANOREXIA 1 0.0001
733 HAEMORRHAGE INTRACRANIAL 1 0.0001
734 TENDONITIS 1 0.0001
735 ERUCTATION 1 0.0001
736 ASTHMA 6 0.0001
737 BACK DISORDER 1 0.0001
738 FUNGAL INFECTION 2 0.0001
739 MOVEMENT DISORDER 2 0.0001
740 MUSCLE TIGHTNESS 1 0.0001
741 DELIRIUM 2 0.0001
742 DRUG TOXICITY 1 0.0001
743 BLOOD GLUCOSE DECREASED 3 0.0001
744 CHRONIC KIDNEY DISEASE 5 0.0001
745 DEHYDRATION 8 0.0001
746 MUSCULOSKELETAL DISCOMFORT 1 0.0001
747 AGRANULOCYTOSIS 1 0.0001
748 RENAL INJURY 2 0.0001
749 OXYGEN SATURATION DECREASED 3 0.0001
750 ANXIETY 17 0.0001
751 AMENORRHOEA 1 0.0001
752 MALAISE 26 0.0001
753 COAGULOPATHY 1 0.0001
754 HAEMOGLOBIN DECREASED 6 0.0001
755 DYSPNOEA EXERTIONAL 2 0.0001
756 ORTHOSTATIC HYPOTENSION 1 0.0001
757 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
758 HAEMATURIA 2 0.0001
759 BLOOD UREA INCREASED 1 0.0001
760 DISCOMFORT 3 0.0001
761 LIVER FUNCTION TEST INCREASED 1 0.0001
762 CEREBRAL HAEMORRHAGE 2 0.0001
763 ISCHAEMIC STROKE 1 0.0001
764 ADVERSE EVENT 5 0.0001
765 BLOOD PRESSURE ABNORMAL 1 0.0001
766 HERNIA 1 0.0001
767 DERMATITIS 1 0.0001
768 NECK PAIN 3 0.0001
769 GALLBLADDER DISORDER 1 0.0001
770 DYSURIA 2 0.0001
771 OSTEOMYELITIS 1 0.0001
772 ANAEMIA 10 0.0001
773 INSOMNIA 14 0.0001
774 CRYING 2 0.0001
775 SINUS DISORDER 1 0.0001
776 BONE PAIN 3 0.0001
777 POST PROCEDURAL COMPLICATION 1 0.0001
778 INFUSION RELATED REACTION 3 0.0001
779 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
780 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0001
781 POOR QUALITY SLEEP 1 0.0001
782 FATIGUE 37 0.0001
783 GLOSSODYNIA 1 0.0001
784 MUSCLE SPASMS 9 0.0001
785 VERTIGO 3 0.0001
786 ALANINE AMINOTRANSFERASE INCREASED 3 0.0001
787 MULTI-ORGAN FAILURE 1 0.0001
788 BACK PAIN 11 0.0001
789 PULMONARY HYPERTENSION 1 0.0001
790 PRODUCTIVE COUGH 2 0.0001
791 EATING DISORDER 1 0.0001
792 THROMBOCYTOPENIA 5 0.0001
793 SHOCK 1 0.0001
794 TOOTH LOSS 1 0.0001
795 PREGNANCY 1 0.0001
796 SEPSIS 5 0.0001
797 BLOOD CREATININE INCREASED 3 0.0001
798 HYPOKALAEMIA 2 0.0001
799 NEEDLE ISSUE 1 0.0001
800 NEURALGIA 1 0.0001
801 URINARY TRACT INFECTION 7 0.0001
802 DRUG PRESCRIBING ERROR 1 0.0001
803 FREQUENT BOWEL MOVEMENTS 1 0.0001
804 UNDERDOSE 3 0.0001
805 RESPIRATORY TRACT INFECTION 1 0.0001
806 ENCEPHALOPATHY 1 0.0001
807 LOCALISED INFECTION 1 0.0001
808 APPLICATION SITE PRURITUS 1 0.0001
809 SKIN BURNING SENSATION 3 0.0001
810 HYPOPHAGIA 1 0.0001
811 TREATMENT NONCOMPLIANCE 2 0.0000
812 RESPIRATORY FAILURE 3 0.0000
813 WOUND 1 0.0000
814 HYPOGLYCAEMIA 2 0.0000
815 CEREBRAL INFARCTION 1 0.0000
816 SINUSITIS 4 0.0000
817 DEAFNESS 1 0.0000
818 INJURY 3 0.0000
819 BRONCHITIS 3 0.0000
820 DEMENTIA 1 0.0000
821 SKIN EXFOLIATION 3 0.0000
822 LIMB INJURY 1 0.0000
823 ABDOMINAL PAIN LOWER 1 0.0000
824 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
825 ARTHRITIS 3 0.0000
826 RENAL FAILURE ACUTE 2 0.0000
827 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
828 PROCEDURAL PAIN 1 0.0000
829 JOINT STIFFNESS 1 0.0000
830 UNEVALUABLE EVENT 3 0.0000
831 GASTRITIS 1 0.0000
832 ACNE 3 0.0000
833 PANCYTOPENIA 2 0.0000
834 INFECTION 5 0.0000
835 CONFUSIONAL STATE 6 0.0000
836 HAEMATOMA 1 0.0000
837 ARTHROPATHY 2 0.0000
838 PAIN OF SKIN 1 0.0000
839 DISTURBANCE IN ATTENTION 2 0.0000
840 BLOOD BILIRUBIN INCREASED 1 0.0000
841 HAEMOPTYSIS 1 0.0000
842 ABDOMINAL PAIN 8 0.0000
843 APPLICATION SITE ERYTHEMA 1 0.0000
844 PRODUCT USE ISSUE 6 0.0000
845 TACHYCARDIA 3 0.0000
846 PAIN IN JAW 1 0.0000
847 DRY SKIN 4 0.0000
848 ANHEDONIA 1 0.0000
849 ABNORMAL DREAMS 1 0.0000
850 ILLNESS 2 0.0000
851 MIGRAINE 3 0.0000
852 CARDIAC FAILURE CONGESTIVE 3 0.0000
853 BLOOD POTASSIUM DECREASED 1 0.0000
854 METABOLIC ACIDOSIS 1 0.0000
855 NIGHT SWEATS 1 0.0000
856 RESPIRATORY ARREST 1 0.0000
857 DIARRHOEA 20 0.0000
858 PLEURAL EFFUSION 2 0.0000
859 HEPATIC FAILURE 1 0.0000
860 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
861 IMPAIRED HEALING 1 0.0000
862 IRRITABILITY 2 0.0000
863 EYE DISORDER 1 0.0000
864 HEPATIC ENZYME INCREASED 2 0.0000
865 LIVER FUNCTION TEST ABNORMAL 1 0.0000
866 ABDOMINAL DISCOMFORT 5 0.0000
867 CYSTITIS 1 0.0000
868 TYPE 2 DIABETES MELLITUS 1 0.0000
869 CHOLELITHIASIS 1 0.0000
870 ABDOMINAL PAIN UPPER 6 0.0000
871 NERVOUS SYSTEM DISORDER 1 0.0000
872 HOSPITALISATION 4 0.0000
873 HYPOXIA 1 0.0000
874 HYPERKALAEMIA 1 0.0000
875 INJECTION SITE MASS 1 0.0000
876 MOBILITY DECREASED 2 0.0000
877 INTESTINAL OBSTRUCTION 1 0.0000
878 PLATELET COUNT DECREASED 3 0.0000
879 NASOPHARYNGITIS 5 0.0000
880 HEPATIC FUNCTION ABNORMAL 1 0.0000
881 HALLUCINATION 2 0.0000
882 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
883 ACUTE KIDNEY INJURY 4 0.0000
884 FALL 9 0.0000
885 DECREASED APPETITE 6 0.0000
886 THERAPY NON-RESPONDER 1 0.0000
887 RESTLESSNESS 1 0.0000
888 EPISTAXIS 2 0.0000
889 PLASMA CELL MYELOMA 1 0.0000
890 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
891 AGITATION 2 0.0000
892 CONDITION AGGRAVATED 7 0.0000
893 DRY EYE 1 0.0000
894 DRY MOUTH 2 0.0000
895 BLINDNESS 1 0.0000
896 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
897 HYPOACUSIS 1 0.0000
898 ADVERSE DRUG REACTION 2 0.0000
899 RENAL IMPAIRMENT 2 0.0000
900 PRODUCT DOSE OMISSION 2 0.0000
901 SEPTIC SHOCK 1 0.0000
902 OSTEOARTHRITIS 1 0.0000
903 ROAD TRAFFIC ACCIDENT 1 0.0000
904 HYPERTENSION 5 0.0000
905 DISORIENTATION 1 0.0000
906 ABNORMAL BEHAVIOUR 1 0.0000
907 NEUROPATHY PERIPHERAL 2 0.0000
908 DRUG EFFECT INCOMPLETE 1 0.0000
909 EMOTIONAL DISTRESS 3 0.0000
910 COGNITIVE DISORDER 1 0.0000
911 MEMORY IMPAIRMENT 3 0.0000
912 DEPRESSION 5 0.0000
913 DYSPEPSIA 2 0.0000
914 ATRIAL FIBRILLATION 2 0.0000
915 BLOOD GLUCOSE INCREASED 4 0.0000
916 MULTIPLE SCLEROSIS 1 0.0000
917 ARRHYTHMIA 1 0.0000
918 ABDOMINAL DISTENSION 2 0.0000
919 INFLUENZA 2 0.0000
920 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
921 PNEUMONIA 6 0.0000
922 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
923 OEDEMA 1 0.0000
924 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
925 RHEUMATOID ARTHRITIS 2 0.0000
926 FLATULENCE 1 0.0000
927 DEATH 15 0.0000
928 NERVOUSNESS 1 0.0000
929 STOMATITIS 1 0.0000
930 PRODUCT SUBSTITUTION ISSUE 1 0.0000
931 FEBRILE NEUTROPENIA 1 0.0000
932 NEUTROPENIA 2 0.0000
933 SLEEP DISORDER 1 0.0000
934 DRUG EFFECT DECREASED 1 0.0000
935 HOT FLUSH 1 0.0000
936 WEIGHT DECREASED 4 0.0000
937 STRESS 1 0.0000
938 GASTROINTESTINAL DISORDER 1 0.0000
939 DEVICE ISSUE 1 0.0000
940 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
941 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
942 CARDIAC FAILURE 1 0.0000
943 THROMBOSIS 1 0.0000
944 CARDIAC ARREST 1 0.0000
945 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
946 CEREBROVASCULAR ACCIDENT 2 0.0000
947 SUICIDAL IDEATION 1 0.0000
948 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
949 CARDIAC DISORDER 1 0.0000
950 PULMONARY EMBOLISM 1 0.0000
951 BREAST CANCER 1 0.0000
952 VISUAL IMPAIRMENT 1 0.0000
953 DRUG INEFFECTIVE 10 0.0000
954 PSORIASIS 1 0.0000
955 OFF LABEL USE 5 0.0000
956 COVID-19 1 0.0000
957 TOXICITY TO VARIOUS AGENTS 1 0.0000
958 PRODUCT DOSE OMISSION ISSUE 1 0.0000
959 MYOCARDIAL INFARCTION 1 0.0000
960 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
961 ALOPECIA 1 0.0000
962 SOMNOLENCE 1 0.0000
963 DRUG DOSE OMISSION 1 0.0000
964 CONSTIPATION 1 0.0000